Referências
Aqui estão algumas das referências listadas neste serviço. Se você for pesquisador em algum campo científico que considera correlacionado com o nosso trabalho faça contato conosco, para que seja possível divulgar o seu material.
Você pode escrever para: INFO@abortonanuvem.com
Leitura geral:
Estudos abrangentes
1. Grossman,|Daniel, Charlotte Ellertson, David A. Grimes and Dilys Walker. (2004) Routine Follow-up Visits After First-Trimester Induced Abortion. Obstetrics and Gynecology (103)4:738-745
2. Ellertson, Charlotte, Batya Elul, Shuha Ambardekar, Lindy Wood, Julie Carroll and Kurus Coyaji. (2000) Accuracy of assessment of pregnancy duration by women seeking early abortions. Lancet 355: 877-881.
3. International Consortium for Medical Abortion. (2004) Medical Abortion: Expanding Access to Safe Abortion and Saving Women’s Lives. Statement from: Medical Abortion: An International Forum on Policies, Programmes and Services, 17-20 October 2004, Johannesburg, South Africa.Medical Abortion Consortium (Retrieved July 26, 2005)
4. The Population Council. (1998) Medical Methods of Early Abortion in Developing Countries: Consensus Statement. Contraception 58:257-59.
5. Harper, Cynthia, Charlotte Ellertson and Beverly Winikoff. (2002) Could American women use mifepristone-misoprostol pills safely with less medical supervision? Contraception 65:133-142.
6. Wiebe, Ellen, Edith Guilbert, Francis Jacot, Caitlin Shannon and Beverly Winikoff. (2004) A Fatal Case of Clostridium sordellii Septic Shock Syndrome Associated With Medical Abortion. Obstetrics and Gynecology 104(5):1142-44.
7. Monday, July 18, 2005 7:38:39 PM ET, Abortion pill maker alerts doctors to five deaths. Reuters, Washington. Retrieved July 19, 2005.
8. Basu, Ranjan, Tina Gundlach, and Margaret Tasker. (2003) Mifepristone and misoprostol for medical termination of pregnancy: the effectiveness of a flexible regimen. Journal of Family Planning and Reproductive Health Care 29(3):139-41.
9. Stubblefield, Phillip G., Sacheen Carr-Ellis, and Lynn Borgatta. (2004) Methods for Induced Abortion. Obstetrics and Gynecology 104(1): 174-185.
10. Hausknecht, R. (2003) Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception 61:463-65.
11. Allen, Rebecca H., Carolyn Westhoff, Lara De Nonno, Stephen L. Fielding, and Eric A. Schaff. (2001) Curettage After Mifepristone-Induced Abortion: Frequency, Timing, and Indications.Obstetrics and Gynecology 98(1): 101-6.
12. Hamoda, Haitham, Premila W. Ashok, Gillian M. M. Flett and Allan Templeton. (2003) Medical abortion at 64 to 91 days of gestation: A review of 483 consecutive cases. American Journal of Obstetrics and Gynecology 188(5): 1315-19.
13. Monday, July 19, 2005, 2 More Women Die After Abortion Pills, Gardiner Harris. New York Times Retrieved July 20, 2005.
14. Hamoda, Haitham, Premila W. Ashok, Gillian M.M. Flett, and Allan Templeton. (2005) Medical abortion at 9-13 weeks gestation: a review of 1076 consecutive cases. Contraception 71: 327-332.
15. Ashok, Premila W., Avril Kidd, Gillian M.M. Flett, Ann Fitzmaurice, Wendy Graham and Allan Templeton. (2002) A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Human Reproduction (17)1: 92-98.
16. Ashok, Premila W., Allan Templeton, Prabhath T. Wagaarachchi, and Gillian M.M. Flett. (2002) Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. British Journal of Obstetrics and Gynaecology 109: 1281-1289.
17. MedlinePlus Medical Encyclopedia, Ectopic pregnancy
18. Kruse, Beth, Suzanne Poppema, Mitchell D. Creinin and Maureen Paul. (2000) Management of side effects and complications in medical abortion. American Journal of Obstetrics and Gynecology 183(2):S65-S75.
19. Allan Guttmacher Institute. (1999) Sharing Responsibility: Women, Society and Abortion Worldwide. Alllan Guttmacher Institute
20. Shannon, C., L. Perry Brothers, Neena M. Philip, and Beverly Winikoff. (2004) Infection after medical abortion: a review of the literature. Contraception 70:183-190.
21. Shannon, C., L. P. Brothers, N. Philip and B. Winikoff. (2004) Ectopic Pregnancy and Medical Abortion. Obstetrics and Gynecology. 104(1):161-167.
22. McGregor JA, Soper DE, Lovell G, Todd JK. (1989) Maternal deaths associated with Clostridium sordellii infection. American Journal of Obstetrics and Gynecology 161(4):987-95.
23. Gray, Richard. Doctors let 50 women abort babies at home. Scotland on Sunday. July 3, 2005:10
24. Gideon Koren, Lavinia Schuler. Taking drugs during pregnancy. How safe is unsafe? Canadian Family Physician. Vol 47: Mai 2001
25. David S. Newberger, M.D. Down syndrome: Prenatal risk assessment and diagnosis. American Family Physician, Vol. 62/No. 4 (August 15, 2000)
26. Essential medicines, WHO Model list (revised March 2005), page 20. WHO
27. Hedley, Ellertson, Trussell ed, Accounting for time: Insights from a life-table analysis of the efficacy of medical abortion. American Journal of Obstetrics and Gyneacology (2004) 191, pp 1928-33
28. Hamoda, Ashok, Flett, Templeton, A randomized controlled trial of Mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG 2005 Aug; 112(8): 1102-8
29. Hannafin B, Lovecchio F, Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin? Am J Emerg Med. 2006 Jul;24(4):487-9.
30. “Frequently asked clinical questions about medical abortion”, WHO
31. Repeat Abortion in the United States Jones RK, Singh S, Finer LB, Frohwirth LF, Occasional Report No. 29, November 2006, p.13
32. Pauleta JR, Clode N, Graça LM, Expectant management of incomplete abortion in the first trimester, Int J Gynaecol Obstet. 2009 Mar 28.
33. Rachael L. McEwing, Nigel G. Anderson, Jeremy B. A. Meates, Richard B. Allen, Greg T. M. Phillipson, and J. Elisabeth Wells. Sonographic Appearances of the Endometrium After Termination of Pregnancy in Asymptomatic Versus Symptomatic Women JUM May 2009 28:579-586
34. Bracken H. (2010); Home administration of misoprostol for early medical abortion in India; International Journal of Gynecology and Obstetrics; 108; 228 – 232
35. Creinin M.D., Schreiber C.A., Bednarek P., Lintu H., Wagner M.S., Meyn L.A. (2007); Mifepristone and Misoprostol Administered Simultaneously Versus 24 Hours Apart for Abortion: A Randomized Controlled Trial; Obstetrics & Gynecology; 109 (4); 885–94
36. Fjerstad M., Sivin I., Lichtenberg E.S., Trussell J., Cleland K., Cullins V. (2009); Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days; Contraception; 80; 282 – 286
37. Heikinheimo O., Gissler M., Suhonen S. (2008); Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion; Contraception; 78; 229 – 154
38. Henderson J.T., Hwang A.C., Harper C.C., Stewart F.H. (2005); Safety of mifepristone abortions in clinical use; Contraception; 72; 175 – 178
39. Von Hertzen H., Piaggio G., Wojdyla D., Marions L., My Huong N.T., Tang O.S. et al. (2009); Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial; The World Health Organization Journal compilation: RCOG 2009 BJOG An International Journal of Obstetrics and Gynaecology
40. Knudsen U.B. (2001); First trimester abortion with mifepristone and vaginal Misoprostol; Contraception; 63; 247 – 250
41. Li Y.T., Hou G.Q., Chen T.H., Chu Y.C., Lin T.C., Kuan L.C., et al. (2008); High-Dose Misoprostol as An Alternative Therapy After Failed Medical Abortion; Taiwan Journal of Obstetrics and Gynecology; 47 (4); 408 – 411
42. Livshits A., Machtinger R., David L.B., Spira M., Moshe-Zahav A., Seidman D.S.; Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study; Fertility and Sterility; 91 (5); 1877 – 1880
43. Manaktala U., Singla R., Rathore A.M., Garg S. (2007); Low Dose Mifepristone And Vaginal Misoprostol: A Safe Option For Termination Of Pregnancy Up To 63 Days; The Internet Journal of Gynecology and Obstetrics; 8 (1)
44. Middleton T., Schaff E., , Fielding S.L., Scahill M., Shannon C., Westheimer E., et al. (2005); Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period; Contraception; 72; 328– 332
45. Nobili M.P., Piergrossi S., Brusati V., Moja E.A. (2007); The effect of patient-centered contraceptive counseling in women who undergo a voluntary termination of pregnancy; Patient Education and Counseling; 65; 361–368
46. Perriera L.K., Reeves M.F., Chena B.A., Hohmanna H.L., Hayesa J., Creinin M.D. (2010); Feasibility of telephone follow-up after medical abortion; Contraception; 81; 143–229
47. Raghavan S., Comendant R., Digol I., Ungureanu S., Friptu V, Bracken H., et al. (2009); Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days’ gestational age: a randomized controlled trial of sublingual and oral Misoprostol; Contraception; 79; 84 – 90
48. Raghavan S., Comendant R., Digol I., Ungureanu S., Dondiuc I., Turcanu S., et al. (2010); Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days’ LMP: a randomized controlled trial; Contraception; unknown
49. Reeves M.F., Kudva A., Creinin M.D. (2008); Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac; Contraception; 79; 332 – 335
50. Schaff E.A., Fielding S.L., Westhoff C. (2002); Randomized trial of oral versus vaginal Misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy; Contraception; 66; 247 – 250
51. Schaff E.A., Fielding S.L., Westhoff C., Ellertson C, Eisinger S.H., Stadalius L.S., et al. (2000); Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion; Journal of the American Medical Association; 284; 1948 – 53
52. Shannon C.S., Winikoff B., Hausknecht R., Schaff E., Blumenthal P.D., Oyer D., et. al. (2005); Multicenter Trial of a Simplified Mifepristone Medical Abortion Regimen; Obstetrics & Gynecology; 105 (2); 345 – 351
53. Winikoff B., Dzuba I.G., Creinin M.D., Crowden W.A., Goldberg A.B., Gonzales J., et al. (2008); Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion: A Randomized Controlled Trial; Obstetrics & Gynecology; 112 (6); 1303 – 1310
54. Fiala C, Gemzel-Danielsson K (2006) Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception. 2006 Jul;74(1): 66-86
55. Gemzell-Danielsson K, Lalitkumar S. (2008) Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters May;16(31 Suppl): 162-72
56. Ho PC, Blumenthal PD, Gemzell-Danielsson K, Gómez Ponce de León R, Mittal S, Tang OS. (2007) Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2: S178-81
57. The National Library of Medicine (NLM) Uses of Misoprostol in Obstetrics and Gynecology
58. Oxford Journals Pharmacokinetics of different routes of administration of misoprostol
59. Contraception Journal, A review of evidence for safe abortion care
60. American Congress of Obstetricians and Gynecologists (ACOG) Government Mandates: Ultrasound and Abortion
Leitura complementar:
Estudos sobre Psicologia
1. Adler NE, David HP, Major BN, Roth SH, Russo NF, Wyatt GE. (1992) Psychological factors in abortion: a review.American Psychology 47:1194-204.
2. Dagg PKB. (1991) The psychological sequelae of therapeutic abortion: denied and completed. American Journal of Psychiatry 148:578-85.
3. Stotland NL. (1997) Psychosocial aspects of induced abortion. Clinical Obstetrics and Gynecology 40:673-86.
4. Advancing New Standards in Reproductive Health – ANSIRH Social and Emotional Aspects of Abortion
5. Warren JT, Harvey SM, Henderson JT. Do depression and low self-esteem follow abortion among adolescents? Evidence from a national study.Perspectives in Sexual and Reproductive Health. 2010 Dec;42(4):230-5.
6. Major B, Appelbaum M, Beckman L, Dutton MA, Russo NF, West C. Abortion and mental health: Evaluating the evidence. American Psychology. 2009 Dec;64(9):863-90.
7. Steinberg JR, Finer LB. Examining the association of abortion history and current mental health: A reanalysis of the National Comorbidity Survey using a common-risk-factors model. Social Science in Medicine. 2011 Jan;72(1):72-82.
8. The concept of “post-abortion syndrome” as a traumatic response to abortion expert research on “post-abortion syndrome.”
9. Mental health issues and abortion – ANSIRH Mental health issues and abortion
Leitura complementar:
Estudos sobre História
1. Resources on the history of abortion, to mark the 36th anniversary of Roe v. Wade (revised December 2008)
2. History of abortion History of abortion from Wikipedia
3. The World’s Smelliest Spice, Saudi Armaco World, 2009
Leitura complementar:
Documentos
Detalhes da Publicação
Name: Abortion Policies and Reproductive Health around the World
Authors: United Nations
Publication date: 2014
ISBN: 978-92-1-151521-3
Downloads
Enviamos um SMS com a nova senha
Aguarde até 15 minutos pois cada conta permite somente 02 pedidos durante toda sua vida